skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: assunto: Adult remover assunto: Male remover Life Sciences & Biomedicine remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A comparison of three measures of upper limb function in Friedreich ataxia
A comparison of three measures of upper limb function in Friedreich ataxia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A comparison of three measures of upper limb function in Friedreich ataxia

Corben, L. A. ; Tai, G. ; Wilson, C. ; Collins, V. ; Churchyard, A. J. ; Delatycki, M. B.

Journal of neurology, 2010-04, Vol.257 (4), p.518-523 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
2
The Evaluation of Subcutaneous Proleukin ® (interleukin-2) in a Randomized International Trial : rationale, design, and methods of ESPRIT
The Evaluation of Subcutaneous Proleukin ® (interleukin-2) in a Randomized International Trial : rationale, design, and methods of ESPRIT
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Evaluation of Subcutaneous Proleukin ® (interleukin-2) in a Randomized International Trial : rationale, design, and methods of ESPRIT

Emery, Sean ; Abrams, Donald I. ; Cooper, David A. ; Darbyshire, Janet H. ; Lane, H.Clifford ; Lundgren, Jens D. ; Neaton, James D.

Controlled clinical trials, 2002-04, Vol.23 (2), p.198-220 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Closeout of Four Phase II Vanguard Trials and Patient Rollover into a Large International Phase III HIV Clinical Endpoint Trial
Closeout of Four Phase II Vanguard Trials and Patient Rollover into a Large International Phase III HIV Clinical Endpoint Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Closeout of Four Phase II Vanguard Trials and Patient Rollover into a Large International Phase III HIV Clinical Endpoint Trial

Tavel, Jorge A. ; Fosdick, Lisa

Controlled clinical trials, 2001-02, Vol.22 (1), p.42-48 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Relationship between Serum Omega-3 Fatty Acid and Asthma Endpoints
Relationship between Serum Omega-3 Fatty Acid and Asthma Endpoints
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relationship between Serum Omega-3 Fatty Acid and Asthma Endpoints

Adams, Shahieda ; Lopata, Andreas L ; Smuts, Cornelius M ; Baatjies, Roslynn ; Jeebhay, Mohamed F

International journal of environmental research and public health, 2018-12, Vol.16 (1), p.43 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
5
Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)
Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)

Revicki, D. A. ; Camilleri, M. ; Kuo, B. ; Szarka, L. A. ; McCormack, J. ; Parkman, H. P.

Neurogastroenterology and motility, 2012-05, Vol.24 (5), p.456-463 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Challenges assessing clinical endpoints in early Huntington disease
Challenges assessing clinical endpoints in early Huntington disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Challenges assessing clinical endpoints in early Huntington disease

Paulsen, Jane S. ; Wang, Chiachi ; Duff, Kevin ; Barker, Roger ; Nance, Martha ; Beglinger, Leigh ; Moser, David ; Williams, Janet K. ; Simpson, Sheila ; Langbehn, Douglas ; van Kammen, Daniel P.

Movement disorders, 2010-11, Vol.25 (15), p.2595-2603 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
7
No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study
No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study
Material Type:
Artigo 		Adicionar ao Meu Espaço

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study

Kappos, Ludwig ; Havrdova, Eva ; Giovannoni, Gavin ; Khatri, Bhupendra O ; Gauthier, Susan A ; Greenberg, Steven J ; You, Xiaojun ; Wang, Ping ; Giannattasio, Giorgio

Multiple sclerosis, 2017-11, Vol.23 (13), p.1736-1747 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
8
Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study
Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study

Havrdova, Eva ; Giovannoni, Gavin ; Stefoski, Dusan ; Forster, Samantha ; Umans, Kimberly ; Mehta, Lahar ; Greenberg, Steven ; Elkins, Jacob

Multiple sclerosis, 2014-04, Vol.20 (4), p.464-470 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
9
Defining the contribution of SNPs identified in asthma GWAS to clinical variables in asthmatic children
Defining the contribution of SNPs identified in asthma GWAS to clinical variables in asthmatic children
Material Type:
Artigo 		Adicionar ao Meu Espaço

Defining the contribution of SNPs identified in asthma GWAS to clinical variables in asthmatic children

Tulah, Asif S ; Holloway, John W ; Sayers, Ian

BMC genetics, 2013-09, Vol.14 (1), p.100-100, Article 100 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
10
Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer
Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer

Claret, Laurent ; Lu, Jian-Feng ; Sun, Yu-Nien ; Bruno, René

Cancer chemotherapy and pharmacology, 2010-11, Vol.66 (6), p.1141-1149 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2002  (1)
  2. 2002Até2009  (2)
  3. 2010Até2011  (3)
  4. 2012Até2013  (2)
  5. Após 2013  (3)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.